Drugs & TargetsFree City of Hope signs licensing agreement with Scopus BioPharma to develop novel, targeted IO gene therapy June 19, 2020Vol.46 No.25
Drugs & TargetsFree Royal Philips and MD Anderson to facilitate personalized oncology treatments and clinical trial matching based on genomic markers June 19, 2020Vol.46 No.25
Drugs & TargetsFree Isoray, University of Cincinnati physicians company sign research agreement to study head and neck cancers June 19, 2020Vol.46 No.25
Drugs & TargetsFree Nivolumab approved by FDA for esophageal squamous cell carcinoma June 12, 2020Vol.46 No.24
Drugs & TargetsFree Atezolizumab + bevacizumab approved by FDA for unresectable HCC June 05, 2020Vol.46 No.23
Drugs & TargetsFree Ramucirumab + erlotinib approved by FDA for first-line metastatic NSCLC June 05, 2020Vol.46 No.23
Drugs & TargetsFree Piqray receives positive CHMP opinion to treat HR+/HER2- advanced breast cancer with a PIK3CA mutation June 05, 2020Vol.46 No.23
Drugs & TargetsFree Sarclisa approved by European Commission for adults with relapsed and refractory multiple myeloma June 05, 2020Vol.46 No.23
